Cells as protein factories and the use of genomics to improve the manufacture of Biologics
With the introduction of recombinant DNA technology two decades ago, a new class of pharmaceuticals (known as biologics) began to reach patients and proliferate to treat other human diseases. Although the first human recombinant proteins (such as insulin) were analogs for the molecules previously obtained from cadavers or animals, the technology brought about many new…